跳至主要内容
临床试验/EUCTR2007-004074-10-IT
EUCTR2007-004074-10-IT进行中(未招募)不适用

?Idiopathic sudden sensorineural hearing loss treatment by Infliximab injection (TNF-alfa blocker)? - ND

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2008年1月4日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • idiopathic sudden sensorineural hearing loss (severe or profound pure tone average) no responders to protocol therapy; caucasian race subjects; age range 20-80 years; female and males.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • familiar history of hearing loss; immunodeficiency disease; severe heart and vascular disease; pharmacological intolerance; cases responders to protocol therapy.

研究者

发起方
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

相似试验

?Idiopathic sudden sensorineural hearing loss... | 临床试验